What Is the Doctrine of Equivalents?

The doctrine of equivalents is a legal concept used in patent law to protect inventors from having their inventions “stolen” or copied. In the United States, the doctrine of equivalents grants patent holders a degree of protection for their inventions beyond the explicit protection offered by the patent’s claims. Essentially, this doctrine allows patent holders to pursue makers of an invention that is not strictly similar to the patent holder’s invention, but which performs the same function.

Legislative History

The doctrine of equivalents was first enacted in the United States under the Patent Act of 1952. In its interpretation of the act, the Supreme Court of the United States declared that patent holders should receive protection for their inventions, even if such inventions are not identical to the patented invention. This interpretation made its way into the United States Code of Laws as codified in the new Patent Act, and is often referred to as the doctrine of equivalents.

Use of the Doctrine of Equivalents

The doctrine of equivalents is an important part of patent law, as it provides some flexibility to patent holders in protecting their inventions. For example, a patent holder may use the doctrine of equivalents to pursue legal action against a maker of a similar but slightly different version of the patent holder’s invention. The protection offered by the doctrine of equivalents is important for inventors, as it can provide an additional layer of protection from copycats and plagiarists.

Want to explore this concept further? Ask Legalpedia AI — get a plain-English explanation instantly, free.

Modern Examples

An example of the doctrine of equivalents at work can be found in the Supreme Court case Merck v. Mylan. In this case, the Supreme Court ruled in favor of Merck, which purchased the patent for their drug ezetimibe from a Canadian company. Following the acquisition of the patent, Merck sued Mylan, a pharmaceutical company, for infringement of their patent, as Mylan was selling a generic form of the drug. The Supreme Court ultimately found that Mylan’s generic drug was covered by the doctrine of equivalents, and thus an infringement of Merck’s patent.

Related Legal Concepts

The doctrine of equivalents operates alongside other fundamental legal doctrines that shape how courts interpret and apply legal protections. While this patent law principle focuses on substantial similarity in function, other doctrines like the clean hands doctrine ensure that parties seeking legal remedies have acted ethically, and the plain view doctrine governs what evidence can be considered in legal proceedings. Understanding how the doctrine of equivalents fits within the broader framework of legal doctrines helps illuminate the balance courts must strike between protecting innovation and preventing overreach in intellectual property claims.

The Bottom Line

The doctrine of equivalents serves as a crucial safeguard in patent law, ensuring that inventors cannot easily circumvent patent protections through minor modifications that preserve the essential function of an invention. This doctrine strikes an important balance between rewarding genuine innovation and preventing trivial design-around attempts that would undermine patent rights. For guidance specific to your situation, always consult a qualified, licensed attorney.